By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
DenyAccept
< BACK TO NEWS

Tough questions, few answers: The FDA wrestles with its approach to AI in medicine

SOURCE
STAT
DATE PUBLISHED
28
April
2022
RELATED PROGRAMME
Jameel Clinic
RELATED PEOPLE
Regina Barzilay
Read full story >

Related news

Yicai Global

World laureates forum to convene in Shanghai this november

20
September
2023
The Economist

How scientists are using artificial intelligence

13
September
2023
MIT Computer Science & Artificial Intelligence Laboratory

Katabi earns SIGCOMM Lifetime Achievement Award

12
September
2023
CNN

AI's impact on different jobs across the labor market

5
September
2023
Axios

Sizing up AI's promise and limitations in cancer detection

5
September
2023
Financial Times

Superbugs: Why it's so hard to stop the 'silent pandemic'

28
August
2023
Vox

AI-discovered drugs will be for sale sooner than you think

25
August
2023
MIT News

How to help high schoolers prepare for the rise of artificial intelligence

24
August
2023
MIT News

MIT researchers combine deep learning and physics to fix motion-corrupted MRI scans

17
August
2023
Medical Xpress

How machine learning models can amplify inequities in medical diagnosis and treatment

17
August
2023
Undark

Opinion: AI alone won’t solve the problem of antibiotic resistance

10
August
2023
Diagnostic Imaging

Mammography-based deep learning model may help detect precancerous changes in high-risk women

27
July
2023
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.